EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation

Jennifer Berkman, Ellie J Maas iD, E DeBortoli, Clare A Primiero, H Peter Soyer iD, Aideen McInerney-Leo

Pigment Cell & Melanoma Research · 2025-09 · 38 (5)

DOI: 10.1111/pcmr.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 26.09.2025. Verfasst von Jennifer Berkman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Melanoma, Breast Neoplasms, Cyclin-Dependent Kinase Inhibitor p16, Germ-Line Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports co‐segregation of a pathogenic CDKN2A variant with both melanoma and breast cancer in a four‐generation pedigree. Eighteen individuals were test positive ( n = 10), obligate ( n = 5) or assumed carriers ( n = 3) of the CDKN2A variant. Eleven of these had multiple melanomas, with initial diagnoses from teens to fifties. Six of thirteen female carriers had breast cancer ( n = 5 test positive, n = 1 assumed carrier), with diagnoses ranging from thirties to sixties. Additional cancer diagnoses included pancreatic, and head and neck cancers. This study illustrates a possible genotype–phenotype association between a pathogenic CDKN2A variant and the co‐occurrence of melanoma and breast cancer in a hereditary context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaBreast NeoplasmsCyclin-Dependent Kinase Inhibitor p16Germ-Line MutationGenetic Association StudiesGenetic Predisposition to DiseaseHumansFemaleMiddle AgedAdultPedigreeMaleAdolescentYoung AdultAged

Stichwörter der Autor:innen

CDKN2Abreast cancerfamilialgermlinemelanoma

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, human

Autor:innen und Institutionen

  • Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
  • Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Ellie J Maas, H Peter Soyer

Zitieren

APA

Berkman, J., Maas, E. J., DeBortoli, E., Primiero, C. A., Soyer, H. P., & McInerney-Leo, A. (2025). Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation. Pigment Cell & Melanoma Research, 38(5). https://doi.org/10.1111/pcmr.70055

Vancouver

Berkman J, Maas EJ, DeBortoli E, Primiero CA, Soyer HP, McInerney-Leo A. Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation. Pigment Cell & Melanoma Research. 2025;38(5). doi:10.1111/pcmr.70055

BibTeX
@article{Berkman2025,
  author = {Berkman, Jennifer and Maas, Ellie J and DeBortoli, E and Primiero, Clare A and Soyer, H Peter and McInerney-Leo, Aideen},
  title = {Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation},
  journal = {Pigment Cell & Melanoma Research},
  year = {2025},
  volume = {38},
  number = {5},
  doi = {10.1111/pcmr.70055}
}
Kostenlos starten →